Institutional investors purchased a net $209.4 thousand shares of SCMP during the quarter ended September 2016. This may signal that the smart money is gaining interest in this company as the 41.26% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Major industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
LSV ASSET MANAGEMENT Bought 1.2 Million shares of Sucampo Pharmaceuticals I...